Mats Persson
CEO
Pharmaceuticals
Hamlet Pharma
Sweden
Biography
Mats is a molecular biologist by training and received his PhD 1991. He has a broad knowledge from Drug Development and has held several senior positions within R&D. He has been a member of the R&D leadership team at LEO Pharma in Denmark where he was responsible for external R&D collaborations including academic partnerships and commercial alliances. Mats has also more than 20 years’ experience from clinical research and development from AstraZeneca and from development projects in clinical phase I to phase IV
Research Interest
Drug Development, Immunology,Endocrinology
